MKI67 and breast carcinoma: In terms of breast cancer histology, 20/26 (77 %) of patients with lobular carcinomas (ILCs) demonstrated a reduction in Ki67 > 50 % during NET monotherapy, compared to 29/61 (48 %) of IC NSTs (p = 0.02, Table 2).